The funding will be used to expand the firm's global services, enhance its core platforms, and accelerate the development of pathology foundational models.

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

FDA officials said that the draft guidance is meant to address recommendations from two reports on the agency's response to COVID-19.

The TissueCypher assay is designed to identify patients with Barrett's esophagus who are at risk of progressing to esophageal cancer.

Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.

NEW YORK – Canadian point-of-care imaging firm MolecuLight on Monday announced that it has secured a $27.5 million investment from asset management firm Hayfin Capital Management.

Under the agreement, Sysmex will distribute and service in Canada Sentinel Diagnostics' SentiFit 270 and SentiFit 800 analyzers for fecal immunochemical testing.

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

The government alleges Labcorp and UHS delayed submission of orders for tests by Caris Life Sciences to enable improper billings to Medicare for those tests.

Firms in the space advanced solutions to stratify sepsis patients and accelerated time-to-results to find out the cause of infections.